Navigation Links
TonoPach

ProductsTonoPach
Company Neuvas, Inc.
Item TonoPach
Features The TonoPachs patented technology combines CCT and IOP in a single, inexpensive, easy-to-use instrument. The TonoPach has been designed to measure intraocular pressure in millions of patients who are presently improperly diagnosed for glaucoma and ocular hypertension.
Description The TonoPach is a device intended for highly accurate measurements of intraocular pressure (IOP). IOP remains the single most important metric for the diagnosis and treatment of glaucoma. However, as discovered in a large, randomized, five-year National Institute of Health (NIH) study published in mid-2002, the patients central cornea thickness (CCT) is an important and necessary biometric parameter in risk assessment for this patient population.
Info Neuvas, Inc.
Customer Service:
Web site: http://www.retinapharma.com

Related medicine products :

1. GonoGen™
TAG: TonoPach
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...breathing passage, which results due to smoking is...y 2020. // Called Chronic Obstructive Pulmonary ...ealth problems: chronic-obstructive bronchitis and...nlike simple bronchitis, the breathing passages na...
...water stored in plastic containers for a very long...lease a deadly toxin named as antimony to the wate...er the water is stored, reported the online editio...ert William Shotyk tested ground water and 15 type...
...e is an appropriate climate where new ideas can th...climate. // There are a variety of social problems...ills and resources. Collaboration is an essential ...on is only useful when there is application for th...
...as in public glare for the wrong reasons, having u...d and for not being party to a movement that promo...ds Agency got after Tesco, soon after the latter r...alth warnings on products at traffic lights. Tesco...
Other Medicine News:Health News:Health Care System in US Needs a Change 2
(Date:8/14/2008)... Aug. 14 /- Pharmasset, Inc...l company committed to,discovering, developing and...ions, reported unaudited financial results for the...set reported a net loss attributable to,common sto... $0.69 for the,quarter ended June 30, 2008, as com...
(Date:8/14/2008)...) Technology Evaluated to Enable Targeting and Inc...equencing, LEXINGTON, Mass. and HEIDELBERG, Germa...ional Genomics Research Institute (TGen) today ann...Gen will evaluate,Next-Generation-Sequencing equip...m(R) Microarray Technology., febit,s HybSelect(TM...
(Date:8/13/2008)... /- As biotechnology,pharm...y move clinical,trials beyond their own borders to...urope and South America, complicated regulatory en...siness, according to an analysis by,Aon Corporatio...ap provides,those companies a visual representatio...
(Date:8/13/2008)...no(TM) - proves the ability to automatically measu...g samples, SANTA CLARA, Calif., Aug. 13 /PRNewswi...ard: NWCI) a cardiac diagnostic and services compa...al validation study of QTinno(TM),(the "NCE3 Study...eading,cardiac safety expert with extensive experi...
Breaking Medicine Technology:Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9febit and TGen Collaborate to Study New DNA Capture Method 2febit and TGen Collaborate to Study New DNA Capture Method 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 4NewCardio Announces Positive Results From Third Clinical Validation Study 2NewCardio Announces Positive Results From Third Clinical Validation Study 3NewCardio Announces Positive Results From Third Clinical Validation Study 4NewCardio Announces Positive Results From Third Clinical Validation Study 5Researchers Create Protective Sac for Growing Stem Cells 15336 1Researchers Create Protective Sac for Growing Stem Cells 15336 2Kinetic Technologies Makers of Conquer 28R 29 Introduces New Website 15334 1ProActive Remedies LLC Announces Launch of New Allergy Medication 15332 1ProActive Remedies LLC Announces Launch of New Allergy Medication 15332 2Highmark Prominent Part of Pittsburgh City Skyline to Go Dark for One Hour to Support the Environment 15330 1Highmark Prominent Part of Pittsburgh City Skyline to Go Dark for One Hour to Support the Environment 15330 2
...zation with a Bavituximab Equivalent and Irradiate...From 0% in Controls in a,Preclinical Model of Brai...18, 2007,/PRNewswire-FirstCall/ -- Peregrine Pharm...cal company developing targeted,monoclonal antibod...rus (HCV) infection, today announced preclinical s...
..., Wash., April 18, 2007 /PRNewswire-FirstCall/ -- ...Falla, Ph.D, Chief,Scientific Officer, will presen...ll molecule peptide (lipohexapeptide) technology,a... will take place,at the Boston Convention & Ex... 9th. Dr. Falla,s presentation is scheduled for,We...
Other Medicine Technology:Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 2Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 3Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 4Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 5Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 6Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 2Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 3Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 4